Real-World Outcomes of Resected EGFR-Mutated NSCLC Patients Treated With Adjuvant EGFR-TKI in China
Clinical trial NCT07593248 · RECRUITING
Trial details
- NCT number
- NCT07593248
- Sponsor
- AstraZeneca
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-06-22
- Primary completion
- 2031-06-30
- Enrollment
- 2000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.